Catalyst Wire Dossier Catalyst Wire Dossier

rAHF-PFM (recombinant and protein-free Factor VIII)

recombinant and protein-free Factor VIII · Baxalta (now part of Shire)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAHF-PFM (recombinant and protein-free Factor VIII), covering 2021-08-24 to 2021-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 [Phase 2, Phase 3]

See pricing